Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alternative RNA Splicing02:18

Alternative RNA Splicing

24.5K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
24.5K
Alternative RNA Splicing02:18

Alternative RNA Splicing

4.7K
4.7K
RNA Splicing01:32

RNA Splicing

60.2K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.2K
Pre-mRNA Processing: RNA Splicing01:36

Pre-mRNA Processing: RNA Splicing

6.4K
6.4K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

11.6K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.6K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

3.2K
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vitro expansion of stem-like memory T cells via D-mannose supplementation.

Methods in cell biology·2026
Same author

Decoding TCR specificity and T cell fate at the immunological synapse.

The Journal of experimental medicine·2026
Same author

Sequential transcriptional waves and NF-κB-driven chromatin remodeling direct drug-induced dedifferentiation in cancer.

Nature communications·2026
Same author

Extracellular CD44 lactylation impairs CD8<sup>+</sup> T cell function in KRAS-mutant colorectal cancer.

Nature metabolism·2026
Same author

NF-κB: master regulator of cellular responses in health and disease.

Immunity & inflammation·2026
Same author

Chronic TCR signaling-driven suppression of the FOXO1-KLHL6 axis promotes T cell exhaustion.

Immunity & inflammation·2026

Related Experiment Video

Updated: Jan 3, 2026

Using the E1A Minigene Tool to Study mRNA Splicing Changes
10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

5.3K

Alternative splicing coupled with transcript degradation modulates OAS1g antiviral activity.

Luke Frankiw1, Mati Mann1, Guideng Li1,2,3

  • 1Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, USA.

RNA (New York, N.Y.)
|November 20, 2019
PubMed
Summary

Researchers found a splice site in Oas1g that controls antiviral immunity. Removing this site boosts antiviral response but increases cell death, revealing a trade-off in innate immunity regulation.

Keywords:
AS-NMDalternative splicingantiviral responseoligoadenylate synthetaseposttranscriptional regulation

More Related Videos

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.3K
A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
08:53

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

Published on: September 15, 2021

3.1K

Related Experiment Videos

Last Updated: Jan 3, 2026

Using the E1A Minigene Tool to Study mRNA Splicing Changes
10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

5.3K
Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.3K
A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
08:53

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

Published on: September 15, 2021

3.1K

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Innate immunity relies on precise gene expression to balance protection and self-damage.
  • The 2-5A antiviral system is a key component of innate immune responses.
  • Alternative splicing is a known regulatory mechanism in gene expression.

Purpose of the Study:

  • To investigate the role of alternative splicing in regulating Oas1g expression and innate immunity.
  • To understand the functional consequences of a specific alternative splice site in Oas1g.
  • To explore the broader implications of alternative splicing in innate immune gene regulation.

Main Methods:

  • Identification and analysis of alternative splice sites in the Oas1g gene.
  • Assessment of transcript stability and gene expression levels.
  • Evaluation of antiviral response and apoptotic cell death following splice site manipulation.

Main Results:

  • A frequently used alternative splice site in Oas1g generates a transcript targeted for decay.
  • Removal of this splice site enhances Oas1g expression and improves antiviral defense.
  • Eliminating the splice site also increases apoptotic cell death, indicating a regulatory compromise.

Conclusions:

  • Alternative splicing of Oas1g represents a critical regulatory mechanism balancing antiviral protection and host cell damage.
  • This splicing event highlights a trade-off between pathogen defense and potential self-inflicted harm.
  • A broader role for alternative splicing events leading to transcript decay in innate immune gene regulation is suggested.